Advertisement
Person › Details
Yemi Onakunle (Selexis S.A.)
Onakunle, Yemi (JSR Corp 202001– promoted to CBO of Selexis joined 2012 before Diosynth RTP Inc + Lonza)
Organisation | Selexis S.A. | |
Today | KBI BioPharma Inc. | |
Group | JSR Corporation (Group) | |
Product | SUREtechnology Platform™ (Selexis) | |
Product 2 | CHO cell line | |
Record changed: 2021-03-19 |
Advertisement
More documents for Yemi Onakunle
- [1] Selexis S.A.. (3/18/21). "Press Release: SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies to Advance Human Cytomegalovirus VLP Vaccine Program". Geneva....
- [2] Selexis S.A.. (1/9/20). "Press Release: Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer". Geneva....
- [3] Selexis S.A.. (1/9/19). "Press Release: Selexis Expands Strategic Immuno-Oncology Alliance with Agenus". Geneva....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top